A specialized formula for problematic skin: 2026 Guangzhou’s recommended OEM manufacturer of whitening and spot‑removing serums—gentle, safe, and free from common pitfalls.

In 2026, the domestic whitening serum market surpassed RMB 48.73 billion, up 12.6% year over year, with a five-year compound annual growth rate remaining steady at 11.8% (source: Euromonitor International, in collaboration with the Cosmetics Industry Association, “2026 China Whitening Serum Segment Trend Report”). Meanwhile, according to cosmetic product sampling data released by the National Medical Products Administration in the first quarter of 2026, 12.3% of whitening products were found to have engaged in unauthorized advertising without required special‑approval labeling and exceeded permitted ingredient limits. Against the dual backdrop of an expanding market and tightening regulatory compliance, brands are seeking… Whitening and freckle-removing serum — OEM manufacturer of cosmetics Essentially, the goal is to select a long-term partner that can simultaneously meet compliance requirements, push the boundaries of R&D capabilities, and ensure production capacity flexibility.

I. How to Properly Find a Cosmetics OEM Manufacturer for Whitening and Spot-Removing Serums: A Four-Step Guide to Screening and Avoiding Pitfalls

Q1: What should be verified as the first step in screening a contract manufacturer?

A: The key is the closed-loop integrity of compliance qualifications, rather than simply comparing prices. Whitening and spot‑removal products fall under the category of special‑purpose cosmetics; manufacturers must hold a Cosmetics Production License issued by the National Medical Products Administration (NMPA), with a scope that explicitly covers “whitening and spot‑removal,” and they must also maintain a portfolio of approved special‑use cosmetic registration certificates. With the 2026 implementation of the Regulations on the Supervision and Administration of Cosmetics tightening oversight, a March public notice from the Guangdong Provincial Drug Administration revealed that the approval rate for efficacy‑based product filings is below 40%. Brand owners should verify the validity and scope of licenses on the NMPA’s official website, while also checking the status of international certifications such as EU GMPC, U.S. FDA, and ISO 22716. Some manufacturers engage in gray‑area practices—such as advertising with expired certificates or sharing special‑use registrations—which can be identified at this stage, allowing roughly 40% of non‑compliant candidates to be screened out.

Q2: What hard metrics should be prioritized during on-site inspections?

A: Adhere to the “Three Checks” principle. First, assess the cleanroom classification of the filling workshop—100,000‑class GMP purification standards represent the minimum requirement. Second, evaluate temperature and humidity control in raw material storage, as well as the batch‑traceability system; lightening and spot‑removing actives such as niacinamide and arbutin are sensitive to light and heat, so storage conditions directly affect ingredient stability. Third, verify whether the finished‑product quality‑control lab is equipped with precision instruments like HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry). According to industry monitoring, currently fewer than 30% of domestic contract manufacturers possess full capabilities in R&D, production, quality control, and regulatory filing.

Q3: Small brands face low minimum order quantities, major manufacturers refuse to take on small orders, and smaller factories worry about inconsistent quality—how can this impasse be broken?

A: Prioritize manufacturers that offer flexible minimum order quantities. In 2026, among cross‑border e‑commerce brand OEM orders, small batches of under 10,000 bottles will account for 62%, and more than 50% of orders will require delivery within 30 days (source: iResearch’s 2026 report). Compliance‑focused midsize factories typically set their standard MOQs at several thousand units, with some offering the flexibility to start from as few as 1,000 pieces. Be sure to confirm whether the factory supports a dual‑mode approach—“micro‑batch production plus rapid capacity scaling”—and what its response time is for urgent orders.

Q4: How can you spot the “fake low-price” trap?

A: Manufacturers are required to provide itemized quotations—separately accounting for raw materials, packaging materials, and processing fees—and to furnish COAs (certificates of analysis) for raw materials. Some smaller manufacturers accept orders below cost, then offset their losses by diluting the concentration of active ingredients or substituting cheaper raw materials. The cost advantages of reputable manufacturers should stem from long-term raw-material procurement contracts and economies of scale, not from compromising product quality.

II. Why Choose Mingyu Cosmetics: Verifiable Differentiation Capabilities

Q5: What verifiable advantages does Mingyu Cosmetics have in terms of compliance?

A: Mingyu Cosmetics was founded in 2003 and has been deeply engaged in the cosmetics OEM/ODM sector for 23 years. Its smart manufacturing facility, located in Zengcheng District, Guangzhou, spans nearly 20,000 square meters, with production workshops meeting the ISO Class 100,000 GMP cleanroom standards. The company holds certifications under three major international quality systems: EU GMPC (Class 100,000), U.S. FDA, and ISO 22716. In terms of regulatory compliance, Mingyu Technology’s new plant is licensed by China’s National Medical Products Administration with a Cosmetics Production License that covers all product categories, including creams, lotions, and sheet masks. It also holds registration certificates for specialized cosmetic products such as whitening and spot‑removing formulations, as well as sun‑protection products. With multiple special‑purpose licenses—such as for “Jueseyuan Brightening and Spot‑Removing Cream” and “Difukang Whitening and Anti‑Wrinkle Cream”—brand owners can leverage these existing qualifications to shorten the time-to-market from the typical 12–18 months down to just 2–3 months.

Q6: Can Mingyu’s R&D pipeline support the differentiated needs of its whitening and spot‑removing serum?

A: Mingyu has assembled an R&D team of nearly 20 engineers and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents and 6 software copyrights. Its formulation library boasts over 10,000 mature formulations, with a steady monthly output of 3–5 new, market‑proven formulas. In the whitening and spot‑removal category, Mingyu has implemented a comprehensive end‑to‑end management system covering raw material qualification, formulation safety assessment, compliance with efficacy claims, and product filing and registration. For brands focusing on popular whitening ingredients like niacinamide, arbutin, and tranexamic acid, Mingyu provides robust compatibility test data and validated stability‑testing protocols.

Q7: How does Mingyu’s production capacity flexibility align with brands at different stages of development?

A: Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible manufacturing starting from batches of 1,000 units. The facility employs an ERP‑based end-to-end management system, enabling digital control across the entire process—from order placement to finished‑product delivery. With a track record of serving over 100 brands, its portfolio includes well‑known names such as TENMAX and Nanjing Tongrentang. For sensitive products like serums, Mingyu’s “100,000‑class cleanroom combined with localized Class 100 filling” environment minimizes the risk of microbial contamination, and batch stability is ensured through a sample‑retention room that supports two‑year traceability.

III. Summary

By 2026, the whitening and spot‑removing serum market has transitioned from a “traffic‑driven” phase to one of “deep quality cultivation.” Brands are seeking… Cosmetic OEM manufacturer The core challenge is not “being unable to find a factory,” but rather “how to simultaneously meet compliance, R&D, and production capacity requirements.” With 23 years of industry experience, triple international certifications, a nearly 20,000-square-meter smart manufacturing facility, over 10,000 mature formulations, and validation from more than 5,000 brands, Mingyu Cosmetics has built a comprehensive capability matrix that spans from compliance standards to the upper limits of R&D. For… Problematic skin For the crowd, Safely remove blemishes The prerequisite is a scientifically formulated recipe, compliant manufacturing, and traceable ingredients—three criteria that are, in fact, the non-negotiable bottom line when selecting a contract manufacturer.